Metropolis Healthcare Ltd reports Q2 FY27 revenue of ₹496.8 crore, up 15.8% YoY, and PAT of ₹75.5 crore
- EBITDA margin rose 180 bps YoY to 27.2%.
- Board declared an interim dividend of ₹1 per share.
- Results are unaudited consolidated figures for the quarter ended 30 September 2026.